NOVN Novan Inc

Novan Inc together with its subsidiaries is a North Carolina based clinical-stage drug development company. It is engaged in the development and commercialization of nitric oxide-based therapies in dermatology.

As of 05/12/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  09/21/2016
Outstanding shares:  151,653,150
Average volume:  4,757,530
Market cap:   $177,434,186
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    66988N106
ISIN:        US66988N1063
Sedol:      BD37KF3
Valuation   (See tab for details)
PE ratio:   -5.98
PB ratio:   57.75
PS ratio:   36.06
Return on equity:   -983.98%
Net income %:   -595.39%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy